Yahoo Finance

Operations: Biome Australia Limited does not report specific revenue segments.

Market Cap: A$132.61M

Biome Australia Limited, with a market cap of A$132.61 million, has transitioned to profitability, reporting a net income of A$0.43 million for the half year ended December 31, 2024. The company's short-term assets (A$9.8M) comfortably exceed both its short-term (A$5.7M) and long-term liabilities (A$181.8K), indicating solid financial health in the near term. Despite low return on equity at 6.4%, Biome's debt management is strong with more cash than total debt and reduced debt-to-equity ratio over five years from 25.5% to 22.1%. The stock trades significantly below estimated fair value, suggesting potential investment appeal amidst stable weekly volatility.

• Jump into the full analysis health report here for a deeper understanding of Biome Australia.

• Examine Biome Australia's earnings growth report to understand how analysts expect it to perform.

Johns Lyng Group

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: Johns Lyng Group Limited offers integrated building services across Australia, New Zealand, and the United States, with a market cap of A$1.10 billion.

Operations: The company's revenue is primarily derived from Insurance Building and Restoration Services, which generated A$1.08 billion, and Commercial Building Services, which contributed A$88.17 million.

Market Cap: A$1.1B

Johns Lyng Group, with a market cap of A$1.10 billion, demonstrates robust financial health and growth potential. The company's earnings have grown significantly at 30% annually over the past five years, although recent growth has slowed to 2.5%. Trading at 39% below estimated fair value suggests potential undervaluation. Despite an increase in debt-to-equity ratio from 1.9% to 7.4%, debt is well-covered by operating cash flow (85.5%) and interest payments are covered 51 times by EBIT, indicating sound debt management. Additionally, short-term assets exceed liabilities, further supporting its financial stability amidst stable weekly volatility.

• Get an in-depth perspective on Johns Lyng Group's performance by reading our balance sheet health report here.

• Evaluate Johns Lyng Group's prospects by accessing our earnings growth report.

Turning Ideas Into Actions

• Click here to access our complete index of 1,033 ASX Penny Stocks.

• Already own these companies? Link your portfolio to Simply Wall St and get alerts on any new warning signs to your stocks.

• Streamline your investment strategy with Simply Wall St's app for free and benefit from extensive research on stocks across all corners of the world.

Contemplating Other Strategies?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.

• Jump on the AI train with fast growing tech companies forging a new era of innovation.

• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include ASX:ALC ASX:BIO and ASX:JLG.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com